Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Front Neuroendocrinol. 2017 Oct 18;51:14–24. doi: 10.1016/j.yfrne.2017.10.004

Table 2.

Commonly used commercially available oxytocin (OT) and arginine-vasopressin (AVP) receptor agonists and antagonists.

Category Compound Name/acronym Supplier
OTR agonist [Thr4, Gly7]-OT TGOT Abgent; Bachem
WAY267, 464*# N/A Tocris
OTR antagonist d(CH2)5-Tyr(Me)-[Orn8]-vasotocin N/A Bachem
V1aR antagonist d(CH2)5[Try(Me)2]AVP Manning Compound Sigma-Aldrich
SR49059* N/A Tocris; Sigma-Aldrich
V1bR antagonist SSR149415* Nelivaptan Sigma-Aldrich
*

indicates non-peptide agonists/antagonists.

#

is also a V1aR antagonist [126].

HHS Vulnerability Disclosure